FDA issues final rule for device identification system

FDA issues final rule for device identification system
The U.S. Food and Drug Administration has released a final rule for the unique device identification system that, when implemented, will improve patient safety by providing a consistent way to identify approved medical devices.

(HealthDay)—The U.S. Food and Drug Administration has released a final rule for the unique device identification system (UDI) that, when implemented, will improve patient safety by providing a consistent way to identify approved medical devices.

The FDA has worked with industry, the clinical community, and patient and to develop this rule, which builds upon current device industry standards and is a key component of the National Medical Device Post-Market Surveillance System proposed last year.

The UDI system is intended to enhance efficient identification of recalled marketed devices, improve the accuracy and specificity of adverse event reports, and provide a foundation for a global, secure distribution chain. UDI will also offer a clear way of documenting device use in clinical information systems. Class III medical devices will be required to carry the unique identifiers on their label and packaging within one year, and this number and corresponding device information must be submitted to the new database. For most Class II devices, manufacturers will have three years to comply; Class I device manufacturers not exempt from UDI requirements will have five years.

"UDI represents a landmark step in improving , modernizing our post-market for medical devices, and facilitating medical device innovation," Jeffrey Shuren, M.D., director of the FDA's Center for Devices and Radiological Health, said in a statement.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

FDA requires tracking codes on medical implants

Sep 20, 2013

Federal health regulators will begin tracking millions of medical devices, from pacemakers to hip replacements, using a new electronic system designed to protect patients by catching problematic implants earlier.

FDA aims to accelerate medical device reviews

Feb 08, 2011

(AP) -- Federal health officials have proposed a plan that would speed up the approval of innovative medical devices that hold the potential to dramatically improve patients' lives.

Recommended for you

EU regulator: Morning-after pill OK for all women

13 hours ago

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

17 hours ago

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

Zydelig approved for three types of blood cancer

18 hours ago

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Journal raises concern about blood-thinning drug

Jul 23, 2014

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

User comments